AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea flag South Korea · Delayed Price · Currency is KRW
62,500
-3,700 (-5.59%)
At close: Mar 19, 2026
Market Cap1.51T +268.7%
Revenue (ttm)2.17B -56.7%
Net Income-9.73B
EPS-429.00
Shares Out23.34M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume308,917
Average Volume389,627
Open63,800
Previous Close66,200
Day's Range62,000 - 65,200
52-Week Range11,980 - 74,000
Beta1.62
RSI51.14
Earnings Daten/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 397030
Full Company Profile

Financial Performance

Financial Statements